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ORIGINAL ARTICLE
Clinical concentrations of morphine are cytotoxic on
proliferating human fibroblasts in vitro
Jose´ Aguirre, Alain Borgeat, Melanie Hasler, Philipp Bu¨hler and John M. Bonvini
BACKGROUND Morphine and other opioids are routinely
used systemically and as wound infusions in the postopera-
tive period. Their effect on wound and fracture healing
remains unclear.
OBJECTIVE The primary outcome was to assess the poten-
tial cytotoxicity of clinically relevant concentrations of mor-
phine on human fibroblasts.
DESIGN Laboratory in-vitro study.
SETTING Institute of Physiology, Zurich Center for Integra-
tive Human Physiology, University of Zurich.
MATERIALS Monolayers of human fibroblasts.
INTERVENTION(S) Exposure of human fibroblast mono-
layers to several concentrations of morphine, for different
periods of time, with and without an artificially induced
inflammatory process.
MAIN OUTCOME MEASURES Cell count, cell viability, cell
proliferation and apoptosis.
RESULTS A concentration, time and exposure-dependent
cytotoxic effect of morphine-mediated apoptosis was
observed. Simulated inflammatory conditions seemed to
lessen toxic effects.
CONCLUSION Cytotoxic effects of morphine are exposure,
time and concentration dependent. Simulating aspects of
inflammatory conditions seems to increase resistance to
morphine cytotoxicity especially in the presence of higher
concentration and longer exposure times.
Published online 4 August 2016
Introduction
As opioids are still the cornerstone drugs for treatment of
severe pain,1 morphine plays a key role in postoperative
painmanagement. However, opioid usemay be restricted
because of side-effects such as respiratory depression,
nausea, constipation, addiction and tolerance. In the late
1980s, several studies showed that not only do opioids
activate receptors in the brain and spinal cord but also
activate receptors on peripheral sensory neurons.1,2 Since
then, different opioid pathways outside the central ner-
vous system have been described, and new techniques
such as intra-articular injections (local infiltration analge-
sia) and topical wound application have been introduced
into clinical practice.3–5
Many studies have focussed on NSAIDs as potential
causes for non-union after fracture repair,6 but, in a
retrospective study, systemic opioids were also
implicated in these complications.7 However, this latter
finding has not been reproduced in a prospective study.
The mechanism for toxicity after systemic opioids
remains unclear, but in investigations of animal models
where different mechanisms of cellular regulation have
been the focus of attention and in various clinical trials,
direct cell toxicity following topical application of opioids
has been implicated as a possible explanation. However,
in contrast to such observations, in an in-vitro setting,
Haasters et al.8 observed no effect of morphine on either
cell survival, cell metabolism or apoptosis in human
hamstring-derived stem/progenitor cells. Similarly,
studying human osteoblasts in an in-vitro environment,
Matziolis et al.9 observed no negative effects of tramadol,
at clinically used concentrations. Owing to the develop-
ment of modern postoperative pain therapy models
(wound infiltration, continuous wound infusion) and
the crucial role of fibroblasts in wound healing, we
designed this in-vitro study to assess possible morphine
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cytotoxicity and its correlation with drug concentration
and exposure times of up to 9 days. Apoptotic pathways
were primarily investigated as possible mechanisms. In
addition, the effects of simulated aspects of inflammation
on cytotoxicity were also assessed. Despite the negative
findings in the above-mentioned laboratory exper-
iments,8,9 based on previous clinical results,7 we
expected to observe a moderate cytotoxic effect of mor-
phine on human fibroblasts.
Materials and methods
The in-vitro study was based on our previous protocol
involving toxicity of local anaesthetics on human fibro-
blasts.10
Cell cultures
Human osteosarcoma cells (LGC Standard GmbH,
Wesel, Germany), which are osteoblast-like cell types
with the morphology of human fibroblasts (especially
proliferative wound fibroblasts11) were cultured in a-
modified Eagle’s medium (LGC Standard GmbH,
Wesel, Germany) with 10% foetal bovine serum (LGC
Standard GmbH, Wesel, Germany) and 10 000 IU l1
penicillin/streptomycin (LGC Standard GmbH, Wesel,
Germany) at 378C and 5% CO2.
Drugs
Preservative free morphine (Morphin-HCL, Sintetica
SA, Mendrisio, Switzerland) was obtained from our hos-
pital pharmacy. Serial dilutions were performed to
achieve concentrations ranging from 71.3 to
570.68mgml1, corresponding to plasma concentrations
measured in clinical practice.12,13
Peak plasma morphine concentrations are about
0.001 71mgml1mg1 morphine after immediate release
morphine (time to peak, 1 h), 0.000 85mgml1mg1 mor-
phine for controlled release morphine (time to peak,
2.7 h) and 0.000 1425mgml1mg1 morphine for once-
daily morphine (time to peak, 8.5 h). The range chosen in
this study should simulate different concentrations after
injection of morphine (1000mgml1) into a joint/tissue.
Experimental groups
In group 1, cells were exposed to morphine for 2 days,
followed by incubation with normal growth medium
without morphine for a further 7 days. In group 2, cells
were continuously exposed to morphine for the full 9
days. Control cells were incubated with growth med-
ium throughout. In all groups, the medium, with the
appropriate concentration of morphine, was changed
every second day. Tests were performed on days 3, 6
and 9.
To assess the effect of inflammation, three further
groups were studied. These groups corresponded to
the above three groups with the addition of 20 ngml1
lipopolysaccharide (LPS; Fluka, Buchs, Switzerland)
added to the culture medium throughout 9 days.
Cell count
Cells were counted using fluorescence DNA quantitation
assay (Sigma-Aldrich, Buchs, Switzerland) as described
before.14 Briefly, Hoechst 33258 (bisBenzimide H 33258,
Sigma-Aldrich, Buchs , Switzerland) binds specifically to
adjacent adenine–thymine base pairs of DNA. The
resulting fluorescence changes can be measured effi-
ciently at an excitation wavelength of 360 nm and an
emission wavelength of 465 nm.
Cell viability
Tetrazolium bromide assay (Sigma-Aldrich, Buchs,
Switzerland) was used as described before.15 Briefly,
in living cells, mitochondrial dehydrogenases catalyse
tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyl tetrazolium bromide] into formazan crystals. This
reaction can be quantified by ELISA (wavelength 570 to
620 nm).
Cell proliferation
Colorimetric bromodeoxyuridine (BrdU; Invitrogen Ltd,
Paisley, Scotland, UK) analysis was used as described
before.16,17 Briefly, during cell division, BrdU (an
analogue of thymidine) is incorporated into new DNA.
BrdU incorporation can be quantified with an ELISA
reader at 450 nm (reference wavelength 620 nm).
Apoptosis
Caspase-3 activity was determined by measuring proteo-
lytic cleavage of the fluorogenic caspase-3 substrate, Ac-
Asp-Glu-Val-Asp-AMC (Calbiochem, Laeufelfingen,
Switzerland), as described before.10 Briefly, cells were
washed once and incubated with lysis buffer containing
0.1% Triton-100, Sigma-Aldrich, Buchs , Switzerland.
The subsequent fluorescence was measured at an exci-
tation wavelength of 360 nm and an emission wavelength
of 465 nm. Camptothecin was used as a positive control
(4mmol l1).
Twelve samples for each of the above individual tests at
each time point were split evenly between two separate
12 8 Nunc MaxiSorp flat-bottom 96-well plate (Sigma-
Aldrich, Buchs, Switzerland) for analysis, and the results
averaged.
Statistical analysis
Values are expressed as mean (SD). Results are presented
as a percentage of control. Cell count, viability, prolifer-
ation rate, caspase-3 activity and results after LPS
exposure were analysed using three-way analysis of var-
iance. Spearman’s rank correlation coefficient was com-
puted to assess the relationship between the different
variables. OriginPro 8G (OriginLab, Northampton,
Massachusetts, USA) and SPSS (SPSS Vers. 17.0, Inc.,
Cytotoxicity of morphine on fibroblasts 833
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Chicago, Illinois, USA) were used for statistical analyses.
A probability of P< 0.05 was considered statistically
significant.
Results
Cell numbers (DNA quantitation)
Cell count was significantly lower in the presence of
morphine when compared with control (P< 0.05). Expos-
ing cells to morphine for 9 days (group 2) led to a
significant decrease in cell count when compared with
cells with only 2 days’ exposure (group 1, P< 0.001;
Table 1). Simulating aspects of inflammation led to a
significantly higher cell count at the higher morphine
concentration when compared with cells exposed under
normal conditions (P< 0.001; Fig. 1a).
After 2 days’ exposure to the highest concentration of
morphine, simulating inflammatory conditions led to a
significantly higher cell count after 9 days when com-
pared with cells exposed without such simulation
(P< 0.001; Fig. 1b). At the highest morphine concen-
tration, no cells survived 9 days of continuous exposure,
irrespective of simulated inflammation (Fig. 1a).
Cell viability (tetrazolium bromide activity)
Cell viability in surviving cells was significantly lower
after exposure to morphine for 2 days (group 1) when
compared with cells exposed 3 and 6 days (group 2). No
cell survived 9 days of continuous exposure at high
concentrations (Table 1). Simulating aspects of inflam-
matory conditions led to a significantly higher cell
viability when compared with cells exposed under normal
conditions (P< 0.001; Fig. 2).
Cell proliferation (bromodeoxyuridine activity)
Proliferation rate was significantly higher in surviving
cells after exposure to morphine (P< 0.001; Table 1).
In cells exposed for 2 days (group 1) to high concentration
of morphine, simulating aspects of inflammatory con-
ditions led to a significantly lower proliferation rate when
compared with cells exposed to morphine without such
simulation (Fig. 3).
Apoptotic pathway (caspase-3 activity)
Limiting exposure to high concentrations of morphine to
2 days (group 1) led to significantly lower caspase-3
activity when compared with the 9 days’ exposure (group
2, P< 0.001; Table 1). Simulating aspects of inflamma-
tory conditions led to a significantly reduced caspase-3
activity compared with cell without such simulation
(P< 0.001; Fig. 4).
Discussion
The in-vitro study shows that limiting exposure of fibro-
blasts to lower concentrations of morphine and limiting
exposure to 2 days reduces its cytotoxicity when com-
pared with high concentrations and longer exposure
times (9 days). It also shows that exposing cells to
morphine in an environment simulating aspects of
inflammation leads to a higher cell count, higher cell
viability and lower activation of the apoptotic pathway
when compared with a non-inflammatory state.
The present study protocol was based on a previous study
involving toxicity of local anaesthetics on human fibro-
blasts.10 The influence played by opioids on fibroblasts
and osteoblasts remains unclear. In a retrospective study
of humeral shaft fractures, Bhattacharyya et al.7 associated
systemic opioid intake with non-union after 61 to 90 days.
In contrast, in-vitro studies of opioids did not show toxic
effects on cell viability of osteoblasts9 or human ham-
string-derived stem/progenitor cells.8 As postoperative
local application of morphine for pain therapy is becom-
ing more common,4,5 we decided to investigate its
possible cytotoxicity.
We chose a limited (2 days, group 1) and a continuous
exposure (9 days, group 2) to simulate single shot and
continuous morphine usage, respectively. Although, in
clinical practice, continuous exposure is seldom longer
than 2 days, we decided to include a 9 days’ follow-up as
no clinical study has shown for how long and at what
concentrations morphine remains in the tissues after
either a single injection or a continuous infusion.
Furthermore, by simulating inflammation with the
addition of LPS to the cell cultures in our current study,
we also attempted to observe the effect of the inflam-
matory process as it might be found in the acute post-
operative phase. The effects induced by systemic
administration of LPS have been described in the litera-
ture,18 and – recently – in an in-vivo mouse model, the
topical application of LPS at the wound surface has been
observed to influence the inflammatory process and so
promote wound healing on the injured skin.19 However,
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Table 1 Comparison between 2 days’ (group 1) and continuous (group 2) exposure to morphine 570.68mgml-1
DNA MTT BrdU Caspase-3
Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2
Day 3 71.2 (8.60) 50.9 (1.78) 92.5 (2.68) 107.8 (8.22) 145.6 (4.06) 131.9 (5.14) 19.2 (11.01) 1288.1 (50.79)
Day 6 80.2 (4.11) 22.0 (5.05) 99.2 (4.20) 137.6 (5.06) 149.8 (10.15) 153.4 (6.05) 99.6 (11.15) 322.1 (21.01)
Day 9 52.1 (7.08) 0 (0) 56.0 (3.49) 0 (0) 140.0 (8.31) 0 (0) 14.0 (7.40) 0 (0)
Results are expressed as a percentage of control, mean (SD). BrdU, bromodeoxyuridine; MTT, tetrazolium bromide.
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LPS administration is not validated in an in-vitro model
of wound inflammation.
Our results show a small reduction in cell numbers with
low/moderate morphine doses and a significant reduction
in cell numbers in the presence of the highest morphine
concentration, suggesting the possibility of a ‘toxic
threshold’ between morphine doses of 285.34 and
570.68mgml1 (Fig. 1a). Furthermore, limitingmorphine
exposure to 2 days allowed cells to survive 9 days,
whereas no cells survived after 9 days of continuous
exposure to high morphine concentrations (Fig. 1a and
b). Cell viability in the surviving cells was also comprom-
ised after 9 days in group 1 (Fig. 2). These findings concur
with results from different animal experiments which
describe a time-dependent relationship between topical
morphine treatment and wound healing, with a reduction
of myofibroblasts, the progenitors of fibrocytes, which
leads to reduced scar formation.20,21 This is in accordance
with the work of Lam et al.22 in mice; they reported that
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(a) Cell numbers (DNA quantification): dosis effects. Results are a percentage of control values. Cell count was significantly lower in the presence of
morphine when compared with control (P<0.05). At 570.68mg ml1 concentration of morphine, simulating inflammatory conditions with LPS led to
a significantly higher cell count when compared with cells exposed under normal conditions without LPS (P<0.001). P<0.05, P<0.001. (b)
Cell numbers (DNA quantitation): time course. In group 1 (2 days’ exposure to morphine), simulating inflammatory conditions with LPS led to a
significantly higher cell count at 9 days when compared with cells exposed under normal conditions without LPS (P<0.001). When cells were
exposed continuously to morphine, simulated inflammation with LPS had no effect. P<0.001. LPS, lipopolysaccharide.
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Fig. 2
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Cell viability (tetrazolium bromide activity). At the highest concentration of morphine, no cells survived 9 days of continuous exposure to morphine,
with or without simulated inflammation. In the cells exposed to morphine for 2 days (transient exposure), at this high concentration of morphine (group
1), compared with the control cells, there was a significantly lower viability in the surviving cells (P<0.05). Viability of these transiently exposed cells
was significantly higher when inflammatory conditions were simulated (group 1 þ lipopolysaccharide, P<0.001). P<0.05, P<0.001. NS, not
significant.
Fig. 3
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Cell proliferation (BrdU activity). Proliferation rate was significantly higher after exposure to morphine (P<0.001). In cells transiently exposed (group
1) to high concentration of morphine, simulating aspects of inflammatory conditions lead to a significantly lower proliferation rate when compared
with cells exposed to morphine under normal conditions. Cell proliferation (BrdU activity). At 3 and 6 days, the cell proliferation rate after exposure to
morphine (570.68mg ml1) was significantly higher than the control cells (P<0.001). In group 1, cells transiently exposed to this morphine
concentration, simulating inflammatory conditions with LPS resulted in a significantly lower proliferation rate when compared with cells exposed to
morphine under normal conditions without LPS (P<0.05). At this concentration, practically no cell survived 9 days of continuous exposure to
morphine. P<0.05, P<0.001. BrdU, bromodeoxyuridine; LPS, lipopolysaccharide.
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high-dose morphine (intraperitoneal injection of
20mgkg1 day1 for 14 days) resulted in excessive gener-
ation of superoxide anions and impairment of angiogen-
esis with consequent delay in wound healing. A single
injection of morphine 20mgkg1 is equivalent to a
plasma concentration of 2.25mgml1.23 The plasma mor-
phine levels after 14 days of continuous intraperitoneal
administration in that investigation are unknown, as Lam
et al.22 did not measure them. But these results do show
that a negative impact on cell viability can be used for a
positive clinical outcome. Our results are in contrast to
those of Haasters et al.,8 who showed only a small
reduction in the metabolic activity of human tendon
stem/progenitor cells and no cell death after a 6-h
exposure to a morphine concentration of 250mgml1,
which is within the range of our concentrations (71.3 to
570.68mgml1). However, this difference in findings
between their results8 and our present study could be
explained by the very different exposure times (6 h8
versus 2 and 9 days in our present study) and the
moderate concentration chosen.8 In rats, Hanci et al.24
observed no evidence of histological or ultrastructural
damage to wound tissue 8 days after a single infiltration
with 3ml of 5% tramadol. These results, contrasting with
our findings, could also be explained by the shorter opioid
exposure time.
In our study, until all the cells died at the highest
morphine concentration, the cell proliferation rate
was significantly higher after exposure to morphine
(Fig. 3). These findings could be explained by modu-
lation of early growth-related genes as c-jun, c-fos and
c-myc in kidney fibroblasts,25 despite the fact that higher
concentrations of morphine suppress fibroblast prolifer-
ation.25,26 The significance of these finding needs
further investigation.
Caspase-3 activity was significantly higher after exposure
to morphine in a concentration and exposure-dependent
fashion. Increasing the exposure time up to 9 days
(group 2) led to significantly higher caspase-3 activity
(Fig. 4) in the surviving cells, hence predicting the
decline in cell count with time (Fig. 1b). These findings
are in accordance with the results of Hatsukary et al.27 and
Takeuchi et al.28 who showed a dose-dependent acti-
vation of caspase-3, but are in contrast with Haasters
et al.8 who found no induction of apoptosis after a 6-h
exposure to a morphine concentration of 250mgml1.
Again, differences in exposure time could explain these
contrasting outcomes.
Simulating aspects of inflammation led to a significantly
higher cell count after 2 days’ exposure to the highest
morphine concentration (570.68mgml1; Fig. 1a): cell
count increased 4 days after withdrawal of morphine
and remained constant thereafter in contrast to cells
cultured under normal conditions (Fig. 1b). Cell viability
was also higher (Fig. 2). Both the cell proliferation rate
(Fig. 3) and caspase-3 activity (Fig. 4) were lower in cells
Cytotoxicity of morphine on fibroblasts 837
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Apoptotic pathway (caspase-3 activity). When compared with cells only transiently exposed to the drug (group 1), continuous exposure to morphine
(group 2) resulted in a significantly increased caspase-3 activity. Simulating inflammatory conditions with LPS (group 2þLPS) resulted in
significantly less caspase-3 activity when compared with cells exposed under normal conditions without LPS (P<0.001). At the highest
concentration of morphine (570.68mg ml1), no cells survived 9 days of continuous exposure. P<0.05, P<0.001. LPS, lipopolysaccharide.
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exposed to simulated aspects of inflammation. The
reduction in activation of the apoptotic cell death path-
way might explain the higher cell counts in cells exposed
to aspects of inflammation and might be interpreted as a
protective mechanism from morphine cytotoxicity.
There are no published in-vitro data with which to
compare our results.
These findings could also indicate that experiments
conducted with cells harvested from patients during or
after surgery, who are already exposed to an inflammatory
stressor,9,29 might confound toxicity results. However,
the impact of inflammation onmorphine-induced cellular
toxicity needs further investigation.
This study has some limitations. First, we did not include a
second opioid to assess a potential drug-specific impact on
cell viability. Tramadol is also currently used for wound
infiltration30 and would have been an appropriate candi-
date despite negative results in a previous study.9 We
focused on morphine, the most widely used opioid. Sec-
ond, we did not explore other mechanisms of cell death
apart from apoptosis. Nevertheless, apoptosis is one of the
main mechanisms of cell death after exposure to NSAIDs
and local anaesthetics.10,31,32 Third, we did not use
recently cultured cells from human tissue but used cells
from an existing cell line. This model is well established
and has already been used by our group to study the toxic
effects of local anaesthetics.10 Fourth, we investigated
cytotoxicity only at three time points (3, 6 and 9 days)
in our two groups, and increasing the number of time
points investigated may have allowed us to make a more
general recommendation on limiting exposure times to
morphine in clinical settings. Fifth, as previously men-
tioned, in clinical practice, local tissue exposure to 9days of
morphine is not usual, longermorphine use is generally by
systemic administration. However, no clinical study has
shown how long and at which concentrations morphine
remains in the tissues either after single or continuous
topical use, or after systemic administration.
In conclusion, according to the model used, limiting
tissue exposure to morphine to shorter periods of time
and to lower concentrations reduces morphine toxicity on
fibroblasts. In addition, the presence of an inflammatory
reaction in the tissues after surgery could provide some
protection from the toxic effects of morphine. How our
in-vitro results might impact on the clinical use of mor-
phine and other opioids for intra-articular or wound
application must await further evaluation.
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